Viet Nam

Viet Nam

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
6.6 (6.30 - 6.92) 2019 Modelled IHME
6.73 (6.45 - 7.03) 2018 Modelled IHME
6.88 (6.56 - 7.21) 2017 Modelled IHME
7.06 (6.76 - 7.39) 2016 Modelled IHME
7.25 (6.92 - 7.62) 2015 Modelled IHME
7.41 (7.08 - 7.80) 2014 Modelled IHME
7.56 (7.20 - 7.97) 2013 Modelled IHME
7.71 (7.35 - 8.13) 2012 Modelled IHME
7.86 (7.48 - 8.30) 2011 Modelled IHME
8.02 (7.60 - 8.51) 2010 Modelled IHME
8.18 (7.77 - 8.68) 2009 Modelled IHME
8.35 (7.91 - 8.84) 2008 Modelled IHME
8.53 (8.06 - 9.04) 2007 Modelled IHME
8.71 (8.21 - 9.24) 2006 Modelled IHME
8.88 (8.34 - 9.47) 2005 Modelled IHME
9.07 (8.50 - 9.66) 2004 Modelled IHME
9.25 (8.66 - 9.86) 2003 Modelled IHME
9.44 (8.82 - 10.09) 2002 Modelled IHME
9.62 (8.95 - 10.30) 2001 Modelled IHME
9.8 (9.09 - 10.53) 2000 Modelled IHME
9.98 (9.24 - 10.75) 1999 Modelled IHME
10.16 (9.42 - 10.95) 1998 Modelled IHME
10.33 (9.56 - 11.16) 1997 Modelled IHME
10.5 (9.70 - 11.35) 1996 Modelled IHME
10.66 (9.81 - 11.55) 1995 Modelled IHME
10.81 (9.94 - 11.72) 1994 Modelled IHME
10.95 (10.07 - 11.88) 1993 Modelled IHME
11.09 (10.18 - 12.06) 1992 Modelled IHME
11.23 (10.28 - 12.23) 1991 Modelled IHME
11.36 (10.34 - 12.41) 1990 Modelled IHME
6.24 (4.91 - 7.84) 2015 Modelled WHO
10.79 (10.29 - 11.31) 2013 Modelled Schweitzer et al, 2015
8.2 (7.30 - 10.30) 2016 Modelled Razavi-Shearer et al, 2018
10.79 (10.29 - 11.31) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.72 (0.56 - 0.93) 2019 Modelled IHME
0.78 (0.61 - 1) 2018 Modelled IHME
0.81 (0.62 - 1.03) 2017 Modelled IHME
0.82 (0.64 - 1.04) 2016 Modelled IHME
0.83 (0.64 - 1.04) 2015 Modelled IHME
0.88 (0.68 - 1.09) 2014 Modelled IHME
0.97 (0.76 - 1.20) 2013 Modelled IHME
1.08 (0.85 - 1.36) 2012 Modelled IHME
1.2 (0.93 - 1.50) 2011 Modelled IHME
1.29 (1 - 1.63) 2010 Modelled IHME
1.36 (1.05 - 1.71) 2009 Modelled IHME
1.41 (1.09 - 1.76) 2008 Modelled IHME
1.46 (1.14 - 1.82) 2007 Modelled IHME
1.53 (1.18 - 1.93) 2006 Modelled IHME
1.63 (1.25 - 2.05) 2005 Modelled IHME
1.89 (1.45 - 2.38) 2004 Modelled IHME
2.38 (1.82 - 2.99) 2003 Modelled IHME
3.01 (2.29 - 3.76) 2002 Modelled IHME
3.66 (2.79 - 4.59) 2001 Modelled IHME
4.26 (3.23 - 5.35) 2000 Modelled IHME
4.86 (3.74 - 6.05) 1999 Modelled IHME
5.52 (4.29 - 6.84) 1998 Modelled IHME
6.15 (4.80 - 7.57) 1997 Modelled IHME
6.68 (5.21 - 8.22) 1996 Modelled IHME
7 (5.44 - 8.68) 1995 Modelled IHME
7.19 (5.65 - 8.85) 1994 Modelled IHME
7.36 (5.75 - 9.09) 1993 Modelled IHME
7.5 (5.87 - 9.26) 1992 Modelled IHME
7.58 (5.89 - 9.42) 1991 Modelled IHME
7.62 (5.82 - 9.52) 1990 Modelled IHME
1.2 (0.84 - 1.62) 2015 Modelled WHO
2.2 (1.50 - 3.10) 2011 Survey/reported WHO WPRO, Woodring J et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
7,716,530 (7,023,370 - 8,433,260) 1990 Modelled IHME
7,778,240 (7,119,620 - 8,471,720) 1991 Modelled IHME
7,831,480 (7,187,440 - 8,509,790) 1992 Modelled IHME
7,876,850 (7,242,370 - 8,540,610) 1993 Modelled IHME
7,913,350 (7,278,950 - 8,581,850) 1994 Modelled IHME
7,939,340 (7,312,100 - 8,607,240) 1995 Modelled IHME
7,953,000 (7,346,260 - 8,601,240) 1996 Modelled IHME
7,952,080 (7,360,860 - 8,591,860) 1997 Modelled IHME
7,936,930 (7,360,760 - 8,556,920) 1998 Modelled IHME
7,909,460 (7,325,160 - 8,522,370) 1999 Modelled IHME
7,870,620 (7,300,650 - 8,454,930) 2000 Modelled IHME
7,820,600 (7,274,060 - 8,376,370) 2001 Modelled IHME
7,760,810 (7,251,780 - 8,296,520) 2002 Modelled IHME
7,694,380 (7,202,250 - 8,197,920) 2003 Modelled IHME
7,623,320 (7,151,620 - 8,119,610) 2004 Modelled IHME
7,551,640 (7,089,710 - 8,048,610) 2005 Modelled IHME
7,480,040 (7,052,840 - 7,941,240) 2006 Modelled IHME
7,404,910 (6,995,100 - 7,845,190) 2007 Modelled IHME
7,327,020 (6,940,890 - 7,754,680) 2008 Modelled IHME
7,249,140 (6,878,970 - 7,690,620) 2009 Modelled IHME
7,172,530 (6,802,100 - 7,609,620) 2010 Modelled IHME
7,100,540 (6,755,460 - 7,500,770) 2011 Modelled IHME
7,032,010 (6,700,490 - 7,416,260) 2012 Modelled IHME
6,960,420 (6,631,270 - 7,337,120) 2013 Modelled IHME
6,879,750 (6,573,130 - 7,240,590) 2014 Modelled IHME
6,784,720 (6,477,210 - 7,136,630) 2015 Modelled IHME
6,662,360 (6,378,840 - 6,970,680) 2016 Modelled IHME
6,540,060 (6,235,670 - 6,852,270) 2017 Modelled IHME
6,442,300 (6,173,590 - 6,731,060) 2018 Modelled IHME
6,360,160 (6,072,480 - 6,669,630) 2019 Modelled IHME
7,764,000 (6,863,000 - 9,745,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.89 (5.62 - 10.90) 2019 Modelled IHME
8.23 (5.96 - 11.20) 2018 Modelled IHME
8.22 (5.99 - 11) 2017 Modelled IHME
7.73 (5.68 - 10.30) 2016 Modelled IHME
7.25 (5.38 - 9.70) 2015 Modelled IHME
7.19 (5.38 - 9.58) 2014 Modelled IHME
7.26 (5.49 - 9.55) 2013 Modelled IHME
7.35 (5.57 - 9.60) 2012 Modelled IHME
7.49 (5.74 - 9.79) 2011 Modelled IHME
7.59 (5.90 - 9.78) 2010 Modelled IHME
7.67 (6.04 - 9.76) 2009 Modelled IHME
7.77 (6.20 - 9.75) 2008 Modelled IHME
7.96 (6.40 - 9.92) 2007 Modelled IHME
8.12 (6.51 - 9.98) 2006 Modelled IHME
8.32 (6.71 - 10.20) 2005 Modelled IHME
8.46 (6.76 - 10.60) 2004 Modelled IHME
8.59 (6.80 - 10.80) 2003 Modelled IHME
8.73 (6.89 - 11.10) 2002 Modelled IHME
8.91 (6.96 - 11.30) 2001 Modelled IHME
9.11 (6.98 - 11.60) 2000 Modelled IHME
9.42 (7.16 - 12.30) 1999 Modelled IHME
9.71 (7.31 - 12.80) 1998 Modelled IHME
9.98 (7.44 - 13.20) 1997 Modelled IHME
10.2 (7.59 - 13.80) 1996 Modelled IHME
10.4 (7.76 - 14) 1995 Modelled IHME
10.5 (7.87 - 14.20) 1994 Modelled IHME
10.7 (7.82 - 14.40) 1993 Modelled IHME
10.8 (7.81 - 14.50) 1992 Modelled IHME
10.9 (7.88 - 14.80) 1991 Modelled IHME
11 (7.91 - 14.90) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
7,603 (5,418 - 10,480) 2019 Modelled IHME
7,879 (5,711 - 10,711) 2018 Modelled IHME
7,820 (5,696 - 10,475) 2017 Modelled IHME
7,292 (5,364 - 9,747) 2016 Modelled IHME
6,794 (5,042 - 9,085) 2015 Modelled IHME
6,678 (4,998 - 8,898) 2014 Modelled IHME
6,683 (5,050 - 8,796) 2013 Modelled IHME
6,705 (5,082 - 8,757) 2012 Modelled IHME
6,766 (5,189 - 8,842) 2011 Modelled IHME
6,787 (5,275 - 8,752) 2010 Modelled IHME
6,797 (5,352 - 8,650) 2009 Modelled IHME
6,816 (5,437 - 8,554) 2008 Modelled IHME
6,908 (5,557 - 8,611) 2007 Modelled IHME
6,972 (5,596 - 8,575) 2006 Modelled IHME
7,074 (5,706 - 8,684) 2005 Modelled IHME
7,116 (5,682 - 8,883) 2004 Modelled IHME
7,146 (5,655 - 8,996) 2003 Modelled IHME
7,178 (5,665 - 9,099) 2002 Modelled IHME
7,244 (5,656 - 9,216) 2001 Modelled IHME
7,318 (5,608 - 9,327) 2000 Modelled IHME
7,470 (5,675 - 9,765) 1999 Modelled IHME
7,590 (5,715 - 9,999) 1998 Modelled IHME
7,680 (5,725 - 10,136) 1997 Modelled IHME
7,761 (5,747 - 10,443) 1996 Modelled IHME
7,753 (5,785 - 10,455) 1995 Modelled IHME
7,716 (5,765 - 10,431) 1994 Modelled IHME
7,667 (5,625 - 10,369) 1993 Modelled IHME
7,609 (5,516 - 10,237) 1992 Modelled IHME
7,547 (5,461 - 10,285) 1991 Modelled IHME
7,443 (5,373 - 10,145) 1990 Modelled IHME
20,102 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
39 (30 - 51) 2019 Modelled IHME
40 (30 - 50) 2018 Modelled IHME
40 (31 - 50) 2017 Modelled IHME
40 (30 - 50) 2016 Modelled IHME
40 (30 - 50) 2015 Modelled IHME
40 (31 - 51) 2014 Modelled IHME
41 (31 - 51) 2013 Modelled IHME
41 (32 - 52) 2012 Modelled IHME
42 (33 - 53) 2011 Modelled IHME
43 (34 - 53) 2010 Modelled IHME
43 (34 - 54) 2009 Modelled IHME
43 (34 - 54) 2008 Modelled IHME
44 (34 - 54) 2007 Modelled IHME
44 (34 - 54) 2006 Modelled IHME
44 (34 - 55) 2005 Modelled IHME
44 (34 - 55) 2004 Modelled IHME
44 (34 - 56) 2003 Modelled IHME
44 (34 - 56) 2002 Modelled IHME
44 (34 - 56) 2001 Modelled IHME
44 (34 - 57) 2000 Modelled IHME
45 (35 - 57) 1999 Modelled IHME
45 (35 - 57) 1998 Modelled IHME
46 (35 - 58) 1997 Modelled IHME
46 (36 - 58) 1996 Modelled IHME
46 (36 - 58) 1995 Modelled IHME
46 (36 - 58) 1994 Modelled IHME
46 (36 - 58) 1993 Modelled IHME
46 (35 - 58) 1992 Modelled IHME
46 (35 - 58) 1991 Modelled IHME
45 (35 - 58) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
74 2018 Survey/reported WHO/UNICEF
77 2017 Survey/reported WHO/UNICEF
68 2016 Survey/reported WHO/UNICEF
70 2015 Survey/reported WHO/UNICEF
55 2014 Survey/reported WHO/UNICEF
56 2013 Survey/reported WHO/UNICEF
76 2012 Survey/reported WHO/UNICEF
55 2011 Survey/reported WHO/UNICEF
21 2010 Survey/reported WHO/UNICEF
40 2009 Survey/reported WHO/UNICEF
25 2008 Survey/reported WHO/UNICEF
27 2007 Survey/reported WHO/UNICEF
79 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
75 2018 Survey/reported WHO/UNICEF
94 2017 Survey/reported WHO/UNICEF
96 2016 Survey/reported WHO/UNICEF
97 2015 Survey/reported WHO/UNICEF
95 2014 Survey/reported WHO/UNICEF
59 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
95 2011 Survey/reported WHO/UNICEF
88 2010 Survey/reported WHO/UNICEF
94 2009 Survey/reported WHO/UNICEF
87 2008 Survey/reported WHO/UNICEF
67 2007 Survey/reported WHO/UNICEF
93 2006 Survey/reported WHO/UNICEF
94 2005 Survey/reported WHO/UNICEF
94 2004 Survey/reported WHO/UNICEF
78 2003 Survey/reported WHO/UNICEF
89 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
176 (142 - 231) 2016 Survey/reported Larney S et al, 2017
Technical notes
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HBV testing policy
Yes
Year of birth dose introduction
2005
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.66 (1.35 - 2) 2019 Modelled IHME
1.74 (1.41 - 2.10) 2018 Modelled IHME
1.77 (1.44 - 2.14) 2017 Modelled IHME
1.75 (1.43 - 2.10) 2016 Modelled IHME
1.73 (1.41 - 2.09) 2015 Modelled IHME
1.74 (1.42 - 2.09) 2014 Modelled IHME
1.75 (1.44 - 2.10) 2013 Modelled IHME
1.77 (1.46 - 2.12) 2012 Modelled IHME
1.79 (1.48 - 2.15) 2011 Modelled IHME
1.79 (1.48 - 2.16) 2010 Modelled IHME
1.79 (1.48 - 2.15) 2009 Modelled IHME
1.77 (1.48 - 2.12) 2008 Modelled IHME
1.75 (1.46 - 2.09) 2007 Modelled IHME
1.73 (1.45 - 2.06) 2006 Modelled IHME
1.73 (1.44 - 2.04) 2005 Modelled IHME
1.73 (1.44 - 2.04) 2004 Modelled IHME
1.73 (1.44 - 2.06) 2003 Modelled IHME
1.74 (1.44 - 2.10) 2002 Modelled IHME
1.76 (1.42 - 2.15) 2001 Modelled IHME
1.77 (1.42 - 2.21) 2000 Modelled IHME
1.84 (1.46 - 2.28) 1999 Modelled IHME
1.97 (1.56 - 2.45) 1998 Modelled IHME
2.12 (1.69 - 2.64) 1997 Modelled IHME
2.27 (1.80 - 2.82) 1996 Modelled IHME
2.36 (1.87 - 2.94) 1995 Modelled IHME
2.42 (1.93 - 3) 1994 Modelled IHME
2.47 (1.98 - 3.06) 1993 Modelled IHME
2.51 (2.02 - 3.10) 1992 Modelled IHME
2.54 (2.03 - 3.16) 1991 Modelled IHME
2.56 (2.04 - 3.17) 1990 Modelled IHME
1.1 (0.60 - 1.20) 2015 Modelled Blach et al, 2017
1.1 (0.60 - 1.20) 2015 Modelled Blach et al, 2017
Showing out of
Show more

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
58.3 (42.70 - 74) 2014 Modelled Degenhardt L et al, 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
1,735,980 (1,387,060 - 2,156,390) 1990 Modelled IHME
1,761,870 (1,409,620 - 2,187,590) 1991 Modelled IHME
1,774,650 (1,423,900 - 2,190,430) 1992 Modelled IHME
1,776,870 (1,426,070 - 2,202,190) 1993 Modelled IHME
1,770,950 (1,409,610 - 2,198,090) 1994 Modelled IHME
1,759,400 (1,397,040 - 2,194,020) 1995 Modelled IHME
1,716,800 (1,362,620 - 2,136,720) 1996 Modelled IHME
1,633,150 (1,297,980 - 2,030,910) 1997 Modelled IHME
1,536,320 (1,221,980 - 1,916,380) 1998 Modelled IHME
1,456,370 (1,160,970 - 1,803,550) 1999 Modelled IHME
1,424,800 (1,139,610 - 1,770,880) 2000 Modelled IHME
1,428,910 (1,157,660 - 1,746,380) 2001 Modelled IHME
1,434,630 (1,180,240 - 1,725,020) 2002 Modelled IHME
1,442,600 (1,197,970 - 1,711,970) 2003 Modelled IHME
1,453,200 (1,213,890 - 1,715,540) 2004 Modelled IHME
1,467,250 (1,228,060 - 1,737,810) 2005 Modelled IHME
1,489,250 (1,247,820 - 1,768,850) 2006 Modelled IHME
1,519,330 (1,266,910 - 1,814,330) 2007 Modelled IHME
1,552,080 (1,294,290 - 1,857,610) 2008 Modelled IHME
1,582,290 (1,309,790 - 1,902,780) 2009 Modelled IHME
1,604,200 (1,320,210 - 1,934,720) 2010 Modelled IHME
1,614,300 (1,334,140 - 1,939,340) 2011 Modelled IHME
1,616,250 (1,335,250 - 1,935,000) 2012 Modelled IHME
1,614,820 (1,327,200 - 1,934,940) 2013 Modelled IHME
1,615,160 (1,322,620 - 1,938,440) 2014 Modelled IHME
1,622,790 (1,323,740 - 1,961,440) 2015 Modelled IHME
1,651,870 (1,346,800 - 1,985,660) 2016 Modelled IHME
1,680,490 (1,368,460 - 2,032,910) 2017 Modelled IHME
1,661,610 (1,352,370 - 2,007,960) 2018 Modelled IHME
1,598,210 (1,298,300 - 1,931,150) 2019 Modelled IHME
1,066,000 (580,000 - 1,116,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.69 (5.32 - 10.60) 2019 Modelled IHME
7.38 (5.23 - 10.10) 2018 Modelled IHME
7.17 (5.10 - 9.77) 2017 Modelled IHME
7.07 (5.08 - 9.54) 2016 Modelled IHME
6.98 (5.04 - 9.37) 2015 Modelled IHME
6.75 (4.92 - 9.06) 2014 Modelled IHME
6.44 (4.74 - 8.55) 2013 Modelled IHME
6.1 (4.47 - 8.09) 2012 Modelled IHME
5.82 (4.35 - 7.71) 2011 Modelled IHME
5.6 (4.21 - 7.43) 2010 Modelled IHME
5.42 (4.09 - 7.15) 2009 Modelled IHME
5.24 (3.98 - 6.87) 2008 Modelled IHME
5.16 (3.91 - 6.71) 2007 Modelled IHME
5.12 (3.89 - 6.62) 2006 Modelled IHME
5.2 (3.92 - 6.70) 2005 Modelled IHME
5.3 (3.99 - 6.80) 2004 Modelled IHME
5.41 (4.09 - 7.01) 2003 Modelled IHME
5.54 (4.12 - 7.29) 2002 Modelled IHME
5.69 (4.24 - 7.50) 2001 Modelled IHME
5.85 (4.27 - 7.77) 2000 Modelled IHME
6.05 (4.41 - 8.10) 1999 Modelled IHME
6.19 (4.48 - 8.49) 1998 Modelled IHME
6.32 (4.52 - 8.70) 1997 Modelled IHME
6.44 (4.54 - 8.87) 1996 Modelled IHME
6.52 (4.56 - 9.09) 1995 Modelled IHME
6.61 (4.61 - 9.17) 1994 Modelled IHME
6.7 (4.64 - 9.38) 1993 Modelled IHME
6.8 (4.70 - 9.65) 1992 Modelled IHME
6.91 (4.74 - 9.84) 1991 Modelled IHME
6.99 (4.80 - 10) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
7,415 (5,128 - 10,185) 2019 Modelled IHME
7,064 (5,006 - 9,693) 2018 Modelled IHME
6,816 (4,852 - 9,288) 2017 Modelled IHME
6,672 (4,798 - 9,001) 2016 Modelled IHME
6,532 (4,721 - 8,777) 2015 Modelled IHME
6,268 (4,573 - 8,415) 2014 Modelled IHME
5,929 (4,360 - 7,875) 2013 Modelled IHME
5,568 (4,078 - 7,375) 2012 Modelled IHME
5,261 (3,926 - 6,970) 2011 Modelled IHME
5,012 (3,766 - 6,652) 2010 Modelled IHME
4,799 (3,625 - 6,332) 2009 Modelled IHME
4,596 (3,494 - 6,024) 2008 Modelled IHME
4,476 (3,393 - 5,830) 2007 Modelled IHME
4,398 (3,343 - 5,689) 2006 Modelled IHME
4,417 (3,332 - 5,693) 2005 Modelled IHME
4,456 (3,357 - 5,719) 2004 Modelled IHME
4,501 (3,405 - 5,834) 2003 Modelled IHME
4,554 (3,392 - 5,991) 2002 Modelled IHME
4,628 (3,444 - 6,095) 2001 Modelled IHME
4,697 (3,428 - 6,240) 2000 Modelled IHME
4,792 (3,492 - 6,418) 1999 Modelled IHME
4,841 (3,503 - 6,633) 1998 Modelled IHME
4,862 (3,483 - 6,695) 1997 Modelled IHME
4,876 (3,442 - 6,720) 1996 Modelled IHME
4,858 (3,400 - 6,775) 1995 Modelled IHME
4,840 (3,377 - 6,712) 1994 Modelled IHME
4,820 (3,334 - 6,745) 1993 Modelled IHME
4,802 (3,315 - 6,811) 1992 Modelled IHME
4,787 (3,284 - 6,818) 1991 Modelled IHME
4,751 (3,260 - 6,805) 1990 Modelled IHME
5,289 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
24 (15 - 35) 2019 Modelled IHME
24 (15 - 36) 2018 Modelled IHME
24 (15 - 36) 2017 Modelled IHME
25 (15 - 36) 2016 Modelled IHME
25 (15 - 36) 2015 Modelled IHME
25 (15 - 36) 2014 Modelled IHME
24 (15 - 35) 2013 Modelled IHME
24 (15 - 34) 2012 Modelled IHME
23 (14 - 34) 2011 Modelled IHME
23 (14 - 33) 2010 Modelled IHME
23 (14 - 34) 2009 Modelled IHME
23 (14 - 34) 2008 Modelled IHME
23 (14 - 34) 2007 Modelled IHME
23 (14 - 34) 2006 Modelled IHME
23 (14 - 34) 2005 Modelled IHME
23 (14 - 34) 2004 Modelled IHME
24 (14 - 34) 2003 Modelled IHME
24 (14 - 34) 2002 Modelled IHME
24 (14 - 35) 2001 Modelled IHME
24 (14 - 35) 2000 Modelled IHME
24 (14 - 35) 1999 Modelled IHME
24 (14 - 35) 1998 Modelled IHME
23 (14 - 34) 1997 Modelled IHME
23 (14 - 34) 1996 Modelled IHME
23 (14 - 34) 1995 Modelled IHME
23 (14 - 34) 1994 Modelled IHME
23 (14 - 34) 1993 Modelled IHME
24 (14 - 35) 1992 Modelled IHME
24 (14 - 35) 1991 Modelled IHME
24 (14 - 36) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
176 (142 - 231) 2016 Survey/reported Larney S et al, 2017
Technical notes

Number of 28-pill count bottles exported from Indian manufacturers (SOF-based regimens)

National
Download
Value Year Type Source
46,392 2016 Survey/reported CHAI HCV Market Report
46,083 2017 Survey/reported CHAI HCV Market Report
25,370 2018 Survey/reported CHAI HCV Market Report
19,029 2019 Survey/reported CHAI HCV Market Report
Showing out of
Show more
Technical notes

Price of HCV cure (Lowest average FOB price for 3 months of pangenotypic regimens)

National
Download
Value (US $) Year Type Source
387 2016 Survey/reported CHAI HCV Market Report
285 2017 Survey/reported CHAI HCV Market Report
177 2018 Survey/reported CHAI HCV Market Report
195 2019 Survey/reported CHAI HCV Market Report
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HBV testing policy
Yes
Year of birth dose introduction
2005
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
7,603
2019
(5,418 - 10,480)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
7,415
2019
(5,128 - 10,185)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
79 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
176
2016
(142 - 231)
Larney S et al, 2017
Eligible for HBV generic medicines
Eligible for HCV generic medicines